Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-016854

President and CEO sold 18,334 shares at an average $66.35 ($1,216,551)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2021-03-01 Sale −3,370 $64.42 $217,106 2,320,706 I
Watts Ryan J. President and CEO 2021-03-01 Sale −5,885 $65.63 $386,209 2,314,821 I
Watts Ryan J. President and CEO 2021-03-01 Sale −3,453 $66.55 $229,780 2,311,368 I
Watts Ryan J. President and CEO 2021-03-01 Sale −3,339 $67.69 $226,017 2,308,029 I
Watts Ryan J. President and CEO 2021-03-01 Sale −1,625 $68.46 $111,246 2,306,404 I
Watts Ryan J. President and CEO 2021-03-01 Sale −594 $69.65 $41,371 2,305,810 I
Watts Ryan J. President and CEO 2021-03-01 Sale −68 $70.92 $4,823 2,305,742 I
Open-market sales · 18,334 sh · avg $66.35 · $1,216,551
Loading xslF345X03/doc4.xml…